AVS Pulse
2 known investors
AVS develops Pulse IVL, an intravascular lithotripsy system that uses high-frequency pulsatile pressure waves generated from pressurized CO2 to fracture arterial calcium and restore blood flow. The system is being clinically evaluated as a treatment for severe calcified arterial disease, including peripheral, coronary, and carotid applications, for use by physicians treating vascular patients.
Investors Β· 2
Frequently asked questions
- What does AVS Pulse do?
- AVS develops Pulse IVL, an intravascular lithotripsy system that uses high-frequency pulsatile pressure waves generated from pressurized CO2 to fracture arterial calcium and restore blood flow. The system is being clinically evaluated as a treatment for severe calcified arterial disease, including peripheral, coronary, and carotid applications, for use by physicians treating vascular patients.
- Who are AVS Pulse's investors?
- AVS Pulse's investors include Corewell Health Ventures, ID Ventures.